These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 7097299

  • 1. Antibrain antibodies in multiple sclerosis. Relation to clinical variables.
    Ryberg B.
    J Neurol Sci; 1982 May; 54(2):239-61. PubMed ID: 7097299
    [Abstract] [Full Text] [Related]

  • 2. A longitudinal study of antibrain antibodies in multiple sclerosis.
    Ryberg B.
    J Neurol Sci; 1982 May; 54(2):263-70. PubMed ID: 6284884
    [Abstract] [Full Text] [Related]

  • 3. Complement-fixing antibrain antibodies in multiple sclerosis. Comparison of their occurrence in cerebrospinal fluid and serum.
    Ryberg B.
    Acta Neurol Scand; 1976 Jul; 54(1):1-12. PubMed ID: 936972
    [Abstract] [Full Text] [Related]

  • 4. Immunoglobulin characterization by bacterial absorption of antibrain antibodies in multiple sclerosis.
    Ryberg B, Kronvall G.
    Eur Neurol; 1981 Jul; 20(5):374-9. PubMed ID: 7285987
    [Abstract] [Full Text] [Related]

  • 5. Multiple specificities of antibrain antibodies in multiple sclerosis and chronic myelopathy.
    Ryberg B.
    J Neurol Sci; 1978 Oct; 38(3):357-82. PubMed ID: 731263
    [Abstract] [Full Text] [Related]

  • 6. Intrathecal and extrathecal production of antibrain antibodies in multiple sclerosis.
    Ryberg B.
    J Neurol Sci; 1980 Oct; 48(1):1-8. PubMed ID: 7420122
    [Abstract] [Full Text] [Related]

  • 7. CSF and serum ganglioside antibody patterns in MS.
    Stevens A, Weller M, Wiethölter H.
    Acta Neurol Scand; 1992 Nov; 86(5):485-9. PubMed ID: 1481629
    [Abstract] [Full Text] [Related]

  • 8. Complement-fixing antibrain antibodies in multiple sclerosis. A preliminary report.
    Laurell AB, Link H.
    Acta Neurol Scand; 1972 Nov; 48(4):461-6. PubMed ID: 5072655
    [No Abstract] [Full Text] [Related]

  • 9. Antioligodendrocyte antibodies in cerebrospinal fluid of multiple sclerosis and other neurologic diseases.
    Traugott U, Raine CS.
    Neurology; 1981 Jun; 31(6):695-700. PubMed ID: 7017459
    [Abstract] [Full Text] [Related]

  • 10. The ontogenetic mouse brain model employed in the characterization of antibrain antibodies in multiple sclerosis.
    Ryberg B.
    J Neuroimmunol; 1983 Feb; 4(1):9-15. PubMed ID: 6185539
    [Abstract] [Full Text] [Related]

  • 11. Cerebrospinal fluid anti-myelin antibodies are related to magnetic resonance measures of disease activity in multiple sclerosis.
    Vogt MH, Teunissen CE, Iacobaeus E, Heijnen DA, Breij EC, Olsson T, Brundin L, Killestein J, Dijkstra CD.
    J Neurol Neurosurg Psychiatry; 2009 Oct; 80(10):1110-5. PubMed ID: 18931010
    [Abstract] [Full Text] [Related]

  • 12. Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness.
    Link H, Huang YM.
    J Neuroimmunol; 2006 Nov; 180(1-2):17-28. PubMed ID: 16945427
    [Abstract] [Full Text] [Related]

  • 13. Cerebrospinal fluid immunoglobulin quotients, kappa/lambda ratios, and viral antibody titres in neurological disease.
    Roberts-Thomson PJ, Esiri MM, Young AC, Maclennan IC.
    J Clin Pathol; 1976 Dec; 29(12):1105-15. PubMed ID: 188871
    [Abstract] [Full Text] [Related]

  • 14. Elevated antibody reactivity to measles virus NCORE protein among patients with multiple sclerosis and their healthy siblings with intrathecal oligoclonal immunoglobulin G production.
    Persson L, Longhi S, Enarsson J, Andersen O, Haghigi S, Nilsson S, Lagging M, Johansson M, Bergström T.
    J Clin Virol; 2014 Sep; 61(1):107-12. PubMed ID: 25022622
    [Abstract] [Full Text] [Related]

  • 15. Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese.
    Matsuoka T, Matsushita T, Kawano Y, Osoegawa M, Ochi H, Ishizu T, Minohara M, Kikuchi H, Mihara F, Ohyagi Y, Kira J.
    Brain; 2007 May; 130(Pt 5):1206-23. PubMed ID: 17439988
    [Abstract] [Full Text] [Related]

  • 16. Quantitation of measles-specific IgG. Its presence in CSF and brain extracts of patients with multiple sclerosis.
    Mehta PD, Thormar H, Wisniewski HM.
    Arch Neurol; 1980 Oct; 37(10):607-9. PubMed ID: 7425885
    [Abstract] [Full Text] [Related]

  • 17. Multiple sclerosis: search for a serologic inhibitor.
    Ryberg B.
    Acta Neurol Scand; 1980 Sep; 62(3):193-6. PubMed ID: 7211171
    [Abstract] [Full Text] [Related]

  • 18. Different types of antibrain antibodies in multiple sclerosis. Studies employing myelin-deficient mutants of mice.
    Ryberg B, Baumann NA.
    J Neurol Sci; 1983 Mar; 58(3):351-5. PubMed ID: 6842263
    [No Abstract] [Full Text] [Related]

  • 19. Persistence of antibrain antibodies in cerebrospinal fluid during plasmapheresis for multiple sclerosis.
    Ryberg B, Pirskanen R.
    Br Med J (Clin Res Ed); 1985 Sep 28; 291(6499):850-1. PubMed ID: 2996688
    [Abstract] [Full Text] [Related]

  • 20. Multiple sclerosis is associated with enhanced B cell responses to the ganglioside GD1a.
    Matà S, Lolli F, Söderström M, Pinto F, Link H.
    Mult Scler; 1999 Dec 28; 5(6):379-88. PubMed ID: 10618693
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.